These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 15576951)

  • 1. [The present state of vitamin D supplementation or treatment among chronic dialysis patients].
    Suzuki M
    Clin Calcium; 2004 Jan; 14(1):34-8. PubMed ID: 15576951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D treatment in chronic kidney disease.
    Andress DL
    Semin Dial; 2005; 18(4):315-21. PubMed ID: 16076355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D deficiency and associated factors in hemodialysis patients.
    Jean G; Charra B; Chazot C
    J Ren Nutr; 2008 Sep; 18(5):395-9. PubMed ID: 18721733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. When is Vitamin D contraindicated in dialysis patients?
    Lewin E; Olgaard K
    Semin Dial; 2009; 22(3):240-2. PubMed ID: 19572998
    [No Abstract]   [Full Text] [Related]  

  • 6. When is Vitamin D contraindicated in dialysis patients?
    Brown HJ; Cunningham J
    Semin Dial; 2009; 22(3):237-40. PubMed ID: 19572997
    [No Abstract]   [Full Text] [Related]  

  • 7. [Vitamin D and survival of hemodialysis patients].
    Shoji T; Nishizawa Y
    Clin Calcium; 2004 Sep; 14(9):64-8. PubMed ID: 15577113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond minerals and parathyroid hormone: role of active vitamin D in end-stage renal disease.
    Wolf M; Thadhani R
    Semin Dial; 2005; 18(4):302-6. PubMed ID: 16076353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of monthly dose and regular dosing of intravenous active vitamin D use on mortality among patients undergoing hemodialysis.
    St Peter WL; Li S; Liu J; Gilbertson DT; Arneson TJ; Collins AJ
    Pharmacotherapy; 2009 Feb; 29(2):154-64. PubMed ID: 19170585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use and effects of vitamin D compounds in CKD patients.
    Lameire N
    Nephrol Dial Transplant; 2008 Jun; 23(6):1785. PubMed ID: 18467749
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevalence of vitamin D deficiency and the safety and effectiveness of monthly ergocalciferol in hemodialysis patients.
    Saab G; Young DO; Gincherman Y; Giles K; Norwood K; Coyne DW
    Nephron Clin Pract; 2007; 105(3):c132-8. PubMed ID: 17228173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use (or misuse) of vitamin D treatment in CKD and dialysis patients: A recent meta-analysis on vitamin D compounds in chronic kidney disease [1] and an editorial comment [2] accompanying this meta-analysis have already been published. We believe that these papers deserve some comments in the interest of the NDT readership.
    Olgaard K; Lewin E
    Nephrol Dial Transplant; 2008 Jun; 23(6):1786-9; discussion 1789-3. PubMed ID: 18400819
    [No Abstract]   [Full Text] [Related]  

  • 13. An overview of regular dialysis treatment in Japan (as of 31 December 2004).
    Nakai S; Wada A; Kitaoka T; Shinzato T; Nagura Y; Kikuchi K; Masakane I; Shinoda T; Yamazaki C; Sakai R; Marubayashi S; Morita O; Iseki K; Usami T; Kimata N; Suzuki K; Tabei K; Fushimi K; Miwa N; Yauchi M; Wakai K; Akiba T
    Ther Apher Dial; 2006 Dec; 10(6):476-97. PubMed ID: 17199880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D binding protein and the need for vitamin D in hemodialysis patients.
    Speeckaert MM; Glorieux GL; Vanholder R; Van Biesen W; Taes YE; Clement F; Wehlou C; Delanghe JR
    J Ren Nutr; 2008 Sep; 18(5):400-7. PubMed ID: 18721734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients.
    Blair D; Byham-Gray L; Lewis E; McCaffrey S
    J Ren Nutr; 2008 Jul; 18(4):375-82. PubMed ID: 18558303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Japanese Society of Dialysis Therapy treatment guidelines for secondary hyperparathyroidism.
    Kazama JJ
    Ther Apher Dial; 2007 Oct; 11 Suppl 1():S44-7. PubMed ID: 17976085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypovitaminosis D in chronic kidney disease patients: prevalence and treatment.
    Cuppari L; Garcia-Lopes MG
    J Ren Nutr; 2009 Jan; 19(1):38-43. PubMed ID: 19121769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging role for the vitamin D receptor activator (VDRA), paricalcitol, in the treatment of secondary hyperparathyroidism.
    Cozzolino M; Brancaccio D
    Expert Opin Pharmacother; 2008 Apr; 9(6):947-54. PubMed ID: 18377338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vitamin D substitution in chronic renal failure].
    Knoll O
    Internist (Berl); 1997 Oct; 38(10):996. PubMed ID: 9432511
    [No Abstract]   [Full Text] [Related]  

  • 20. Low prevalence of hyperphosphatemia independent of residual renal function in peritoneal dialysis patients.
    Dong J; Wang H; Wang M
    J Ren Nutr; 2007 Nov; 17(6):389-96. PubMed ID: 17971311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.